Pharmaceuticals
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...
Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays
SEOUL, South Korea, June 14, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnostics, to advance discussions on the expansion of it...
Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test
SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix
Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 14, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the...
Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug
SAN FRANCISCO, June 12, 2023 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce...
Fresh2 Group Ltd. Regains Compliance with Nasdaq Listing Requirements
NEW YORK, June 12, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerc...
HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease
* HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. * These mission-aligned companies are collaborating to develop small-molecule therapies for Parkinson's patients, benefiting from their combined expertise in clinical development and disease biology. * T...
The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang
NANCHANG, China, June 12, 2023 /PRNewswire/ -- From 28 to 30 May 2023, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) and the 3rd China IVD Supply Chain Expo (CISCE), recognized as the world's leading in vitro diagnostics (IVD) exhibition, were successfully closed inNanch...
Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking
TAIPEI, June 12, 2023 /PRNewswire/ -- The Taipei City Government continues to promote the "Talent Exchange Program" in support of international entrepreneurs collaborating with companies inTaipei. Serving as the international startup community brand, Taipei Entrepreneurs Hub (TEH) is set to kick ...
Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched
SHANGHAI, June 11, 2023 /PRNewswire/ -- On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of the nine trillion antibody discovery platforms of San...
Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 12, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
Treating COVID with Metformin Reduces Long COVID Rates
MINNEAPOLIS, June 9, 2023 /PRNewswire/ -- A new study published in The Lancet Infectious Diseasessupported by the Parsemus Foundation found a 41% reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42% reduction in emergency room visi...
ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery
NEWARK, Del., June 9, 2023 /PRNewswire/ -- ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch ofin vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to ac...
Anti-Aging and Reproductive Medical Giants Gathered in Hong Kong Dragon's Medical Led Chinese Medical Development
HONG KONG, June 9, 2023 /PRNewswire/ -- Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 atW Hong Kong today, signing strategic partnership agreements with various medical groups fromMainland China, Hong Kong and Taiwan, deepening their long-term strategic pa...
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
CHENGDU, China, June 9, 2023 /PRNewswire/ -- On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China Medical Center, Sichuan University was approved for EUA by relevant authorities in ...
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality
HONG KONG, June 9, 2023 /PRNewswire/ -- On 8 June 2023, the 2023 Fosun International Investor Open Day was held inShanghai. It was the first time that Fosun International had held a large-scale offline open day after the pandemic. More than 100 domestic and foreign investor representatives from B...
Telix Opens European Radiopharmaceutical Production Facility
* Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million) * Located in Walloon's 'Radiopharma Valley' the facility will be a central hub for research and development for the region and f...
IMBdx Expands Targeted Therapies Agreement Following Successful Evaluation of Blood-Based Genomic Profiling Assay in Prostate Cancer
SEOUL, South Korea, June 8, 2023 /PRNewswire/ -- IMBdx Inc., a premier precision cancer diagnostic company accredited by CAP, announced today its plans to broaden its collaboration with AstraZeneca, a leading global biopharmaceutical company. This expansion will advance the shift from tissue to ...
Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023
JINAN, China, June 8, 2023 /PRNewswire/ -- Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the ...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00